Metraipolis › archive › dc_eaa0da94efc9

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial — Europe PMC PMID:41727674

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41727674
DOI
10.1002/pcn5.70302
License (as archived)
solo-consultazione
Archived
2026-11-05T15:37:00.681Z
SHA-256 of the archived text
62d49eade6d3a8fa8421a035e3ba5b2eb440455f1ebd0af899df67b842b2b42b
Stable URL of this page
https://metraipolis.com/documento/dc_eaa0da94efc9

How to cite

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial — Europe PMC PMID:41727674 — Europe PMC (en), https://europepmc.org/article/MED/41727674 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa0da94efc9 (Metraipolis archive dc_eaa0da94efc9, sha256 62d49eade6d3a8fa8421a035e3ba5b2eb440455f1ebd0af899df67b842b2b42b)
BibTeX
@misc{dceaa0da94efc9,
  title = {Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial — Europe PMC PMID:41727674},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41727674},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa0da94efc9; sha256 62d49eade6d3a8fa8421a035e3ba5b2eb440455f1ebd0af899df67b842b2b42b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727674. Agents can read the archived copy with the MCP tool read_document.